Limited stage I and II follicular non-Hodgkin's lymphoma: The Nebraska lymphoma study group experience

Leukemia and Lymphoma

Volumn 34, Issue 3-4, 1999, Pages 273-285

  Tezcan, Haluk ^a,b   Vose, Julie M ^a   Bast, Martin ^a   Bierman, Philip J ^a   Kessinger, Anne ^a   Armitage, James O ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b North Idaho Cancer Center   (United States)

Author keywords

Follicular; Limited stage; Non Hodgkins lymphoma; Stage I; Stage II; Treatment

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; HUMAN; LEUKEMIA REMISSION; MALE; MULTIMODALITY CANCER THERAPY; MYELOPROLIFERATIVE DISORDER; NONHODGKIN LYMPHOMA; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROGNOSIS; SALVAGE THERAPY; SEPSIS;

EID: 0032820155     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909050952     Document Type: Article

References (32)

1. American Cancer Society: Cancer Facts and Figures 1997.
2. Anderson T, Chabner BA, Young RC, et al. (1982) Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute. Cancer 50: 2699-2707.
3. Gallagher CJ, Gregory WM, Jones AE, et al. (1986) Follicular lymphoma: prognostic factors for response and survival. Journal of Clinical Oncology 4: 1470-1480.
4. Simon R, Durrleman S, Hoppe RT, et al. (1988) The Non-Hodgkin Lymphoma Pathologic Classification Project. Long-term follow-up of 1153 patients with non-Hodgkin lymphomas. Annals of Internal Medicine 109: 939-945.
5. Paryani SB, Hoppe RT, Cox RS, et al. (1983) Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stages I and II. Cancer 52: 2300-2307.
6. Gospodarowicz MK, Bush RS, Brown TC, et al. (1984) Prognostic factors in nodular lymphomas: a multivariate analysis based on the Princess Margaret Hospital experience. International Journal of Radiation Oncology, Biology, Physics 10: 489-497.
7. Soubeyran P, Eghbali H, Bonichon F, et al. (1991) Low-grade follicular lymphomas: analysis of prognosis in a series of 281 patients. European Journal of Cancer 27: 1606-1613.
8. Lawrence TS, Urba WJ, Steinberg SM, et al. (1988) Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute. International Journal of Radiation Oncology, Biology, Physics 14: 417-424.
9. Nissen NI, Ersboll J, Hansen HS, et al. (1983) A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas. Cancer 52: 1-7.
10. Monfardini S, Banfi A, Bonadonna G, et al. (1980) Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma. International Journal of Radiation Oncology, Biology, Physics6: 125-134.
11. Horning SJ (1994) Low-grade lymphoma 1993: state of the art. Annals of Oncology 5 Suppl 2: 23-27.
12. Berinstein NL, Reis MD, Ngan BY, et al. (1993) Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma. Journal of Clinical Oncology 11: 1344-1352.
13. McLaughlin P, Fuller LM, Velasquez WS, et al. (1986) Stage I-II follicular lymphoma. Treatment results for 76 patients. Cancer 58: 1596-1602.
14. Anonymous. (1982) National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 49: 2112-2135.
15. Mann RB, Berard CW. (1983) Criteria for the cytologic sub-classification of follicular lymphomas: a proposed alternative method. Hematological Oncology 1: 187-192.
16. Carbone PP, Kaplan HS, Musshoff K, et al. (1971) Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Research 31: 1860-1861.
17. Anderson JR, Vose JM, Bierman PJ, et al. (1993) Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group. Journal of Clinical Oncology 11: 218-224.
18. Kaplan EL, Meier P. (1958) Nonparametric estimation from incomplete observations. J. Am Stat Assoc 53: 457-481.
19. Anderson T, DeVita VT, Jr., Simon RM, et al. (1982) Malignant lymphoma. II Prognostic factors and response to treatment of 473 patients at the National Cancer Institute. Cancer 50: 2708-2721.
20. Vose JM, Armitage JO, Weisenburger DD, et al. (1988) The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma. Journal of Clinical Oncology 6: 1838-1844.
21. Parker D, Alison DL, Barnard DL, et al. (1994) Prognosis in low grade non-Hodgkin's lymphoma: relevance of the number of sites involved, absolute lymphocyte count and serum immunoglobulin level. Hematological Oncology 12: 15-27.
22. Hayabuchi N, Jingu K, Masaki N, et al, (1990) Nodular histiocytic lymphoma, emphasizing results of stage I disease treated by radiotherapy. A report of the Japan Lymphoma Radiation Therapy Study Group (JLRTG). American Journal of Clinical Oncology 13: 501-506.
23. Freedman A, Neuberg D, Gribben J, et al. (1995) Anti-B cell monoclonal antibody treated autologous bone marrow transplantation in patients with low grade non-Hodgkin's lymphomas. In the Proceedings of the Seventh International Symposia Autologous Marrow and Blood Transplantation (Arlington, Texas 1995), edited by Dicke K and Keating A, pp 321-331.
24. Gomez GA, Barcos M, Krishnamsetty RM, et al. (1986) Treatment of early-stages I and II-nodular. poorly differentiated lymphocytic lymphoma. American Journal of Clinical Oncology 9: 40-44.
25. Taylor RE, Allan SG, McIntyre MA, et al. (1988) Low grade stage I and II non-Hodgkin's lymphoma: results of treatment and relapse pattern following therapy. Clinical Radiology 39: 287-290.
26. Reddy S, Saxena VS, Pellettiere EV, et al. (1989) Stage I and II non-Hodgkin's lymphomas: long-term results of radiation therapy. International Journal of Radiation Oncology, Biology, Physics 16: 687-692.
27. Mac Manus MP, Hoppe RT. (1996) Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. Journal of Clinical Oncology 14: 1282-1290.
28. 0 follicular lymphoma? Annals of Oncology 7: 713-718.
29. Solal-Celigny P, Brice P, Brousse N, Caspard H, Bastion Y, Haioun C, Bosly A, Tilly H, Bordessoule D, Sebban C, Harousseau JL, Morel P, Dupas B, Plassart F, Vasile N, Fort N, Leporrier M. (1996) Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol. 14: 514-519.
30. Kay AC, Saven A, Carrera CJ, Carson DA, Thurston D, Beutler E, Piro LD. (1992) 2-Chlorodeoxyadenosine treatment of low-grade lymphomas. J Clin Oncol. 10: 371-377.
31. McLaughlin P, Grillo-Lopez AJ, Link BK, Levy R, Czuczman MS, Williams ME, Heyman MR, Bence-Bruckler I, White CA, Cabanillas F, Jain V, Ho AD, Lister J, Wey K, Shen D, Dallaire BK. (1998) Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol. 16: 2825-2833.
32. Kaminski MS, Gribbin T, Estes J, Ross CW et al. (1998) 1-131 anti-B1 antibody for previously untreated follicular lymphoma: clinical and molecular remissions. Proc Am Soc Clin Onc 17: 6a.